Drugs / TDap
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03383055 Background | Nov 2018 → Jul 2021 | plasma cell myeloma | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDap | “TDap administered on Day 56” NCT03383055 ↗ |